SAN DIEGO (MedPage Today) -- Lowering homocysteine levels with folic acid supplementation yielded no cardiovascular benefit for stable renal transplant recipients, a randomized trial showed.
cardiovascular benefitASN: No CVD Benefit for Folic Acid in Kidney Transplant (CME/CE)MedPage Today Surgery Tue, 11/03/2009 - 11:24
Tags:
|
